Actavia Life Sciences (CE) Stock Quote RASP - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.004

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

0.0016 52 Week Range 0.039

Market Cap

3.087M

Previous Close

0.004

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

771,811,360

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

-0.01

Revenue

Net Profit

-4.44M

Rasna Therapeutics, Inc. (OTC:RASP), a development stage biotechnology company focused on the development of cancer drugs, today announced the successful completion of its merger. Rasna Therapeutics, Inc. is a development stage biotechnology company focused primarily on the development of drug candi... Rasna Therapeutics, Inc. (OTC:RASP), a development stage biotechnology company focused on the development of cancer drugs, today announced the successful completion of its merger. Rasna Therapeutics, Inc. is a development stage biotechnology company focused primarily on the development of drug candidates for leukemia and lymphoma. Abnormal epigenetic modification is recognized to play an important role in the pathogenesis of acute myeloid leukemia (AML), leading to silencing of genes involved in tumor suppression and cellular reproduction. Rasna's focus on inhibition of lysine specific demethylase-1 (LSD1), an enzyme involved in epigenetic control, represents a promising and novel approach towards AML. Rasna has developed novel irreversible and reversible LSD1 regulators that have shown appropriate effects on the LSD1 gene in-vitro and in IND-enabling pre-clinical studies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Reno, Nevada, USA

Founded

Actavia Life Sciences Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker RASP. The last closing price for Actavia Life Sciences (CE) was $0. Over the last year, Actavia Life Sciences (CE) shares have traded in a share price range of $ 0.0016 to $ 0.039.

Actavia Life Sciences (CE) currently has 771,811,360 shares outstanding. The market capitalization of Actavia Life Sciences (CE) is $3.09 million. Actavia Life Sciences (CE) has a price to earnings ratio (PE ratio) of 0.00.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.004	0.004	0.004	0	0	CS
26	-0.01	-71.4285714286	0.014	0.0325	0.0016	12885	0.00757771	CS
52	-0.0037	-48.0519480519	0.0077	0.039	0.0016	9405	0.00976727	CS
156	-0.036	-90	0.04	0.05	0.0001	16362	0.02300427	CS
260	-0.056	-93.3333333333	0.06	0.33	0.0001	28799	0.04760188	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EGRNFChina Evergrande Group (CE)	$ 0.0102 (1,019,900.00%)	900
WRCDFWirecard AG (CE)	$ 0.01 (999,900.00%)	350
CCTLCoin Citadel (PK)	$ 0.0002 (19,900.00%)	1.28M
RDVARDVA Inc (CE)	$ 0.0002 (19,900.00%)	10k
AGRDFMinnova Corporation (PK)	$ 0.0101 (10,000.00%)	10k
ISUNQiSun Inc (CE)	$ 0.000001 (-99.86%)	12.5k
YAYOYayYo Inc (CE)	$ 0.000001 (-99.80%)	44.61k
GBCHFMetaverse Capital Corporation (CE)	$ 0.000001 (-99.00%)	200
NTRRNeutra Corporation (CE)	$ 0.000001 (-99.00%)	40k
BTTXBetter Therapeutics Inc (CE)	$ 0.000001 (-99.00%)	60.2k
THBDThird Bench Inc (PK)	$ 0.0001 (0.00%)	183.32M
RDARRaadr Inc (PK)	$ 0.0006 (-25.00%)	131.72M
BDPTBioadaptives Inc (PK)	$ 0.0001 (-50.00%)	121.82M
GRLFGreen Leaf Innovations Inc (PK)	$ 0.0001 (0.00%)	111.8M
AITXArtificial Intelligence Technology Solutions Inc (PK)	$ 0.003 (-14.29%)	97.54M